CD27 is heterogeneously expressed in multiple myeloma: Low CD27 expression in patients with high-risk disease

British Journal of Haematology

Volumn 121, Issue 1, 2003, Pages 36-43

  Guikema, Jeroen E J ^a,b   Hovenga, Sjoerd ^b   Vellenga, Edo ^b   Condradie, Jelle J ^a,b   Abdulahad, Wayel H ^a,b   Bekkema, Roelof ^b   Smit, Jan W ^b   Zhan, Fenghuang ^c   Shaughnessy Jr , John ^c   Bos, Nicolaas A ^a,b  

^a UNIVERSITY OF GRONINGEN   (Netherlands)

^b UNIVERSITY MEDICAL CENTER GRONINGEN   (Netherlands)

^c UNIVERSITY OF ARKANSAS FOR MEDICAL SCIENCES   (United States)

Author keywords

CD27; cDNA microarray; Immunophenotyping; Multiple myeloma

Indexed keywords

CD19 ANTIGEN; CD27 ANTIGEN; CD38 ANTIGEN; COMPLEMENTARY DNA; SYNDECAN 1;

ARTICLE; BONE MARROW CELL; CELL SUBPOPULATION; CLINICAL ARTICLE; CLONAL VARIATION; COMPARATIVE STUDY; CONTROLLED STUDY; CORRELATION ANALYSIS; DNA MICROARRAY; FLUORESCENCE ACTIVATED CELL SORTING; HIGH RISK POPULATION; HUMAN; HUMAN CELL; IMMUNOPHENOTYPING; MONOCLONAL IMMUNOGLOBULINEMIA; MULTIPLE MYELOMA; PLASMA CELL; PLASMA CELL LEUKEMIA; POLYMERASE CHAIN REACTION; PREVALENCE; PRIORITY JOURNAL; PROGNOSIS; PROTEIN EXPRESSION; RECURRENT DISEASE; REMISSION;

ADP-RIBOSYL CYCLASE; ANTIGENS, CD; ANTIGENS, CD27; ANTIGENS, CD38; CASE-CONTROL STUDIES; HUMANS; IMMUNOPHENOTYPING; MEMBRANE GLYCOPROTEINS; MULTIPLE MYELOMA; OLIGONUCLEOTIDE ARRAY SEQUENCE ANALYSIS; PARAPROTEINEMIAS; PLASMA CELLS; REVERSE TRANSCRIPTASE POLYMERASE CHAIN REACTION; TUMOR CELLS, CULTURED;

EID: 0345373920     PISSN: 00071048     EISSN: None     Source Type: Journal    
DOI: 10.1046/j.1365-2141.2003.04260.x     Document Type: Article

References (40)

1. Agematsu, K., Nagumo, H., Oguchi, Y., Nakazawa, T., Fukushima, K., Yasui, K., Ito, S., Kobata, T., Morimoto, C. & Komiyama, A. (1998) Generation of plasma cells from peripheral blood memory B cells: synergistic effect of interleukin-10 and CD27/CD70 interaction. Blood, 91, 173-180.
2. Agematsu, K., Hokibara, S., Nagumo, H., Shinozaki, K., Yamada, S. & Komiyama, A. (1999) Plasma cell generation from B-lymphocytes via CD27/CD70 interaction. Leukemia and Lymphoma, 35, 219-225.
3. Agematsu, K., Hokibara, S., Nagumo, H. & Komiyama, A. (2000) CD27: a memory B-cell marker. Immunology Today, 21, 204-206.
4. Camerini, D., Walz, G., Loenen, W.A., Borst, J. & Seed, B. (1991) The T cell activation antigen CD27 is a member of the nerve growth factor/tumor necrosis factor receptor gene family. Journal of Immunology, 147, 3165-3169.
5. Durie, B.G.M. & Salmon, S.E. (1975) A clinical staging system for multiple myeloma: correlation of measured myeloma cell mass with presenting clinical features, response to treatment, and survival. Cancer, 36, 842-854.
6. Durie, B.G., Grogan, T.M., Spier, C., Vela, E., Baum, V., Rodriquez, M.A. & Frutiger, Y. (1989) Myelomonocytic myeloma cell line (LB 84-1). Blood, 73, 770-776.
7. Farstad, I.N., Carlsen, H., Morton, H.C. & Brandtzaeg, P. (2000) Immunoglobulin A cell distribution in the human small intestine: phenotypic and functional characteristics. Immunology, 101, 354-363.
8. Goodwin, R.G., Alderson, M.R., Smith, C.A., Armitage, R.J., Vandenbos, T., Jerzy, R., Tough, T.W., Schoenborn, M., Davis-Smith, T., Hennen, K., Falk, B., Cosman, D., Baker, E., Sutherland, G.R., Grabstein, K.H., Farrah, T., Giri, J.G. & Beckmann, M.P. (1993) Molecular and biological characterization of a ligand for CD27 defines a new family of cytokines with homology to tumor necrosis factor. Cell, 73, 447.
9. Gutierrez, N.C., Hernandez, J.M., Garcia, J.L., Canizo, M.C., Gonzalez, M., Hernandez, J., Gonzalez, M.B., Garcia-Marcos, M.A. & San Miguel, J.F. (2001) Differences in genetic changes between multiple myeloma and plasma cell leukemia demonstrated by comparative genomic hybridization. Leukemia, 15, 840-845.
10. Hamilton, M.S., Ball, J., Bromidge, E., Lowe, J. & Franklin, I.M. (1990) Characterization of new IgG lambda myeloma plasma cell line (EJM): a further tool in the investigation of the biology of multiple myeloma. British Journal of Haematology, 75, 378-384.
11. Harada, H., Kawano, M.M., Huang, N., Harada, Y., Iwato, K., Tanabe, O., Tanaka, H., Sakai, A., Asaoku, H. & Kuramoto, A. (1993) Phenotypic difference of normal plasma cells from mature myeloma cells. Blood. 81, 2658-2663.
12. Hintzen, R.Q., de Jong, R., Lens, S.M. & van Lier, R.A.W. (1994a) CD27: marker and mediator of T-cell activation. Immunology Today, 15, 307-311.
13. Hintzen, R.Q., Lens, S.M., Beckmann, M.P., Goodwin, R.G., Lynch, D. & van Lier, R.A.W. (1994b) Characterization of the human CD27 ligand, a novel member of the TNF gene family. Journal of Immunology, 152, 1762.
14. Hintzen, R.Q., Lens, S.M., Koopman, G., Pals, S.T., Spits, H. & van Lier, R.A. (1994c) CD70 represents the human ligand for CD27. International Immunology, 6, 477-480.
15. Jacquot, S., Kobata, T., Iwata, S., Morimoto, C. & Schlossman, S.F. (1997) CD154/CD40 and CD70/CD27 interactions have different and sequential functions in T cell-dependent B cell responses. Journal of Immunology, 159, 2652-2657.
16. Jung, J., Choe, J., Li, L. & Choi, Y.S. (2000) Regulation of CD27 expression in the course of germinal center B cell differentiation: the pivotal role of IL-10. European Journal of Immunology, 30, 2437-2443.
17. Karpas, A., Fisher, P. & Swirsky, D. (1982) Human plasmacytoma with an unusual karyotype growing in vitro and producing light-chain immunoglobulin. Lancet, 1, 931-933.
18. Katagiri, S., Yonezawa, T., Kuyama, J., Kanayama, Y., Nishida, K., Abe, T., Tamaki, T., Ohnishi, M. & Tarui, S. (1985) Two distinct human myeloma cell lines originating from one patient with myeloma. International Journal of Cancer, 36, 241-246.
19. + peripheral blood B cells expressing the CD27 cell surface antigen carry, somatically mutated variable region genes: CD27 as a general marker for somatically mutated (memory) B cells. Journal of Experimental Medicine, 188, 1679-1689.
20. Lemoli, R.M., Fortuna, A., Grande, A., Gamberi, B., Bonsi, L., Fogli, M., Amabile, M., Cavo, M., Ferrari, S. & Tura, S. (1994) Expression and functional role of c-kit ligand (SCF) in human multiple myeloma cells. British Journal of Haematology, 88, 760-769.
21. Lens, S.M., de Jong, R., Hintzen, R.Q., Koopman, G., van Lier R.A. & van Oers, R.H. (1995) CD27-CD70 interaction: unravelling its implication in normal and neoplastic B-cell growth. Leukemia and Lymphoma, 18, 51-59.
22. Lens, S.M., de Jong, R., Hooibrink, B., Koopman, G., Pals, S.T., van Oers, M.H. & van Lier, R.A. (1996a) Phenotype and function of human B cells expressing CD70 (CD27 ligand). European Journal of Immunology, 26, 2964-2971.
23. Lens, S.M., Keehnen, R.M., van Oers, M.H., van Lier, R.A., Pals, S.T. & Koopman, G. (1996b) Identification of a novel subpopulation of germinal center B cells characterized by expression of IgD and CD70. European Journal of Immunology, 26, 1007-1011.
24. van Lier, R.A., Borst, J., Vroom, T.M., Klein, H., Van Mourik, P., Zeijlemaker, W.P. & Melief, C.J. (1987) Tissue distribution and biochemical and functional properties of Tp55 (CD27), a novel T cell differentiation antigen. Journal of Immunology, 139, 1589-1596.
25. Mahmoud, M.S., Fujii, R., Ishikawa, H. & Kawano, M.M. (1999) Enforced CD19 expression leads to growth inhibition and reduced tumorigenicity. Blood, 94, 3551-3558.
26. Matsuoka, Y., Moore, G.E., Yagi, Y. & Pressman, D. (1967) Production of free light chains of immunoglobulin by a hematopoietic cell line derived from a patient with multiple myeloma. Proceedings of the Society for Experimental Biology and Medicine, 125, 1246-1250.
27. Maurer, D., Holter, W., Majdic, O., Fischer, G.F. & Knapp, W. (1990) CD27 expression by a distinct subpopulation of human B lymphocytes. European Journal of Immunology, 20, 2679-2684.
28. Nagumo, H., Agematsu, K., Shinozaki, K., Hokibara, S., Ito, S., Takamoto, M., Nikaido, T., Yasui, K., Uehara, Y., Yachie, A. & Komiyama, A. (1998) CD27/CD70 interaction augments IgE secretion by promoting the differentiation of memory B cells into plasma cells. Journal of Immunology, 161, 6496-6502.
29. Nilsson, K. (1971) Synthesis and secretion of IgE by an established human myeloma cell line. Clinical and Experimental Immunology, 9, 785-793.
30. Ocqueteau, M., Orfao, A., Almeida, J., Blade, J., Gonzalez, M., Garcia-Sanz, R., Lopez-Berges, C., Moro, M.J., Hernandez, J., Escribano, L., Caballero, D., Rozman, M. & San Miguel, J.F. (1998) Immunophenotypic characterization of plasma cells from monoclonal gammopathy of undetermined significance patients. Implications for the differential diagnosis between MGUS and multiple myeloma. American Journal of Pathology, 152, 1655-1665.
31. van Oers, M.H.J., Pals, S.T., Evers, L.M., van der Schoot, C.E., Koopman, G., Bonfrer, J.M.G., von Hintzen, R.Q., dem Borne, A.E.G.K. & van Lier, R.A.W. (1993) Expression and release of CD27 in human B-cell malignancies. Blood, 82, 3430-3436.
32. Okuno, Y., Takahashi, T., Suzuki, A., Ichiba, S., Nakamura, K., Fukumoto, M., Okada, T., Okada, H. & Imura, H. (1991) Establishment and characterization of four myeloma cell lines which are responsive to interleukin-6 for their growth. Leukemia, 5, 585-591.
33. Pegoraro, L., Malavasi, F., Bellone, G., Massaia, M., Boccadoro, M., Saglio, G., Guerrasio, A., Benetton, G., Lombardi, L. & Coda, R. (1989) The human myeloma cell line LP-1: a versatile model in which to study early plasma-cell differentiation and c-myc activation. Blood, 73, 1020-1027.
34. Rawstron, A.C., Fenton, J.A., Ashcroft, J., English, A., Jones, R.A., Richards, S.J., Pratt, G., Owen, R., Davies, F.E., Child, J.A., Jack, A.S. & Morgan, G. (2000) The interleukin-6 receptor alpha-chain (CD126) is expressed by neoplastic but not normal plasma cells. Blood, 96, 3880-3886.
35. Robillard, N., Jego, G., Pellat-Deceunynck, C., Pineau, D., Puthier, D., Mellerin, M.P., Barille, S., Rapp, M.J., Harousseau, J.L., Amiot, M. & Bataille, R. (1998) CD28, a marker associated with tumoral expansion in multiple myeloma. Clinical Cancer Research, 4, 1521-1526.
36. Tangye, S.G., Liu, Y.J., Aversa, G., Phillips, J.H. & de Vries, J.E. (1998) Identification of functional human splenic memory B cells by expression of CD148 and CD27. Journal of Experimental Medicine, 188, 1691-1703.
37. Van Camp, B., Durie, B.G., Spier, C., De Waele, M., Van Riet, I., Vela, E., Frutiger, Y., Richter, L. & Grogan, T.M. (1990) Plasma cells in multiple myeloma express a natural killer cell-associated antigen: CD56 (NKH-1; Leu-19). Blood, 76, 377-382.
38. Wijdenes, J., Vooijs, W.C., Clement, C., Post, J., Morard, F., Vita, N., Laurent, P., Sun, R.X., Klein, B. & Dore, J.M. (1996) A plasmocyte selective monoclonal antibody (B-B4) recognizes syndecan-1. British Journal of Haematology, 94, 318-323.
39. Willems, P., Verhagen, O., Segeren, C., Veenhuizen, P., Guikema, J., Wiemer, E., Groothuis, L., Jong, T.B., Kok, H., Bloem, A., Bos, N., Vellenga, E., Mensink, E., Sonneveld, P., van der Schoot, E. & Raymakers, R. (2000) Consensus strategy to quantitate malignant cells in myeloma patients is validated in a multicenter study. Belgium-Dutch Hematology-Oncology Group. Blood, 96, 63-70.
40. Zhan, F., Hardin, J., Bumm, K., Zheng, M., Tian, E., Sanderson, R., Yang, Y., Wilson, C., Zangari, M., Anaissie, E., Morris, C., Muwalla, F., Van Rhee, F., Fassas, A., Tricot, G., Crowley, J., Barlogie, B. & Shaughnessy, J. (2002) Global gene expression profiling of multiple myeloma, monoclonal gammopathy of undetermined significance and normal bone marrow plasma cells. Blood, 99, 1745-1757.